Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Cartesian Therapeutics, Inc.”

4 pharma patents match "Cartesian Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Cartesian Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Cartesian Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12194078

    Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

    Cartesian Therapeutics, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  2. US 11999773

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  3. US 11220535

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted
  4. US 10934337

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted